APO Research
Talk to an analyst

APO RESEARCH · REPORT

Safety Lancets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Safety Lancets Market Outlook and Growth Opportunities 2026

27 December 2025200 pages

Choose your research edition.

Industry ResearchSafety Lancets Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Safety Lancets Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Safety Lancets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Safety Lancets Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Safety Lancets Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Safety Lancets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Safety Lancets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Safety Lancets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Safety Lancets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Safety Lancets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Safety Lancets market include Tianjin Huahong, SteriLance Medical, Shandong Lianfa, Roche, Guangzhou iCare Medical, B. Braun, UltiMed, Terumo and Sarstedt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Safety Lancets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Safety Lancets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Safety Lancets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Safety Lancets market size, projected growth trends, production technologies, key applications, and end-use industries.

Safety Lancets Segment by Company

Tianjin Huahong

SteriLance Medical

Shandong Lianfa

Roche

Guangzhou iCare Medical

B. Braun

UltiMed

Terumo

Sarstedt

Owen Mumford

Nipro

Lifescan

ICU Medical

HTL-STREFA

HemoCue

Greiner Bio One

Cardinal Health

BD

Ascensia

ARKRAY

Safety Lancets Segment by Type

Safety Lancets with Needle

Safety Lancets with Blade

Safety Lancets Segment by Application

Hospital & Clinics

Home

Other

Safety Lancets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Safety Lancets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Safety Lancets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Safety Lancets significant trends, drivers, influence factors in global and regions.

6. To analyze Safety Lancets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Safety Lancets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Safety Lancets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Safety Lancets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Safety Lancets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Safety Lancets industry.

Chapter 3: Detailed analysis of Safety Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Safety Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Safety Lancets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Safety Lancets Industry Trends Table 2. Safety Lancets Industry Drivers Table 3. Safety Lancets Industry Opportunities and Challenges Table 4. Safety Lancets Industry Restraints Table 5. Global Safety Lancets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Safety Lancets Revenue Share by Company (2021-2026) Table 7. Global Safety Lancets Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Safety Lancets Sales Volume Share by Company (2021-2026) Table 9. Global Safety Lancets Average Price (US$/K Unit) of Company (2021-2026) Table 10. Global Safety Lancets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Safety Lancets Key Company Manufacturing Base & Headquarters Table 12. Global Safety Lancets Company, Product Type & Application Table 13. Global Safety Lancets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Safety Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Safety Lancets with Needle Table 18. Significant Companies of Safety Lancets with Blade Table 19. Global Safety Lancets Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 20. Global Safety Lancets Sales Volume by Type (2021-2026) & (M Units) Table 21. Global Safety Lancets Sales Volume by Type (2027-2032) & (M Units) Table 22. Global Safety Lancets Sales Volume Share by Type (2021-2026) Table 23. Global Safety Lancets Sales Volume Share by Type (2027-2032) Table 24. Global Safety Lancets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Safety Lancets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Safety Lancets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Safety Lancets Sales Value Share by Type (2021-2026) Table 28. Global Safety Lancets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital & Clinics Table 30. Significant Companies of Home Table 31. Significant Companies of Other Table 32. Global Safety Lancets Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 33. Global Safety Lancets Sales Volume by Application (2021-2026) & (M Units) Table 34. Global Safety Lancets Sales Volume by Application (2027-2032) & (M Units) Table 35. Global Safety Lancets Sales Volume Share by Application (2021-2026) Table 36. Global Safety Lancets Sales Volume Share by Application (2027-2032) Table 37. Global Safety Lancets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Safety Lancets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Safety Lancets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Safety Lancets Sales Value Share by Application (2021-2026) Table 41. Global Safety Lancets Sales Value Share by Application (2027-2032) Table 42. Global Safety Lancets Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 43. Global Safety Lancets Sales by Region (2021-2026) & (M Units) Table 44. Global Safety Lancets Sales Market Share by Region (2021-2026) Table 45. Global Safety Lancets Sales by Region (2027-2032) & (M Units) Table 46. Global Safety Lancets Sales Market Share by Region (2027-2032) Table 47. Global Safety Lancets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Safety Lancets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Safety Lancets Sales Value Share by Region (2021-2026) Table 50. Global Safety Lancets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Safety Lancets Sales Value Share by Region (2027-2032) Table 52. Global Safety Lancets Market Average Price (US$/K Unit) by Region (2021-2026) Table 53. Global Safety Lancets Market Average Price (US$/K Unit) by Region (2027-2032) Table 54. Global Safety Lancets Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 55. Global Safety Lancets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Safety Lancets Sales by Country (2021-2026) & (M Units) Table 57. Global Safety Lancets Sales Market Share by Country (2021-2026) Table 58. Global Safety Lancets Sales by Country (2027-2032) & (M Units) Table 59. Global Safety Lancets Sales Market Share by Country (2027-2032) Table 60. Global Safety Lancets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Safety Lancets Sales Value Market Share by Country (2021-2026) Table 62. Global Safety Lancets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Safety Lancets Sales Value Market Share by Country (2027-2032) Table 64. Tianjin Huahong Company Information Table 65. Tianjin Huahong Business Overview Table 66. Tianjin Huahong Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 67. Tianjin Huahong Safety Lancets Product Portfolio Table 68. Tianjin Huahong Recent Development Table 69. SteriLance Medical Company Information Table 70. SteriLance Medical Business Overview Table 71. SteriLance Medical Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 72. SteriLance Medical Safety Lancets Product Portfolio Table 73. SteriLance Medical Recent Development Table 74. Shandong Lianfa Company Information Table 75. Shandong Lianfa Business Overview Table 76. Shandong Lianfa Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 77. Shandong Lianfa Safety Lancets Product Portfolio Table 78. Shandong Lianfa Recent Development Table 79. Roche Company Information Table 80. Roche Business Overview Table 81. Roche Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 82. Roche Safety Lancets Product Portfolio Table 83. Roche Recent Development Table 84. Guangzhou iCare Medical Company Information Table 85. Guangzhou iCare Medical Business Overview Table 86. Guangzhou iCare Medical Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 87. Guangzhou iCare Medical Safety Lancets Product Portfolio Table 88. Guangzhou iCare Medical Recent Development Table 89. B. Braun Company Information Table 90. B. Braun Business Overview Table 91. B. Braun Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 92. B. Braun Safety Lancets Product Portfolio Table 93. B. Braun Recent Development Table 94. UltiMed Company Information Table 95. UltiMed Business Overview Table 96. UltiMed Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 97. UltiMed Safety Lancets Product Portfolio Table 98. UltiMed Recent Development Table 99. Terumo Company Information Table 100. Terumo Business Overview Table 101. Terumo Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 102. Terumo Safety Lancets Product Portfolio Table 103. Terumo Recent Development Table 104. Sarstedt Company Information Table 105. Sarstedt Business Overview Table 106. Sarstedt Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 107. Sarstedt Safety Lancets Product Portfolio Table 108. Sarstedt Recent Development Table 109. Owen Mumford Company Information Table 110. Owen Mumford Business Overview Table 111. Owen Mumford Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 112. Owen Mumford Safety Lancets Product Portfolio Table 113. Owen Mumford Recent Development Table 114. Nipro Company Information Table 115. Nipro Business Overview Table 116. Nipro Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 117. Nipro Safety Lancets Product Portfolio Table 118. Nipro Recent Development Table 119. Lifescan Company Information Table 120. Lifescan Business Overview Table 121. Lifescan Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 122. Lifescan Safety Lancets Product Portfolio Table 123. Lifescan Recent Development Table 124. ICU Medical Company Information Table 125. ICU Medical Business Overview Table 126. ICU Medical Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 127. ICU Medical Safety Lancets Product Portfolio Table 128. ICU Medical Recent Development Table 129. HTL-STREFA Company Information Table 130. HTL-STREFA Business Overview Table 131. HTL-STREFA Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 132. HTL-STREFA Safety Lancets Product Portfolio Table 133. HTL-STREFA Recent Development Table 134. HemoCue Company Information Table 135. HemoCue Business Overview Table 136. HemoCue Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 137. HemoCue Safety Lancets Product Portfolio Table 138. HemoCue Recent Development Table 139. Greiner Bio One Company Information Table 140. Greiner Bio One Business Overview Table 141. Greiner Bio One Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 142. Greiner Bio One Safety Lancets Product Portfolio Table 143. Greiner Bio One Recent Development Table 144. Cardinal Health Company Information Table 145. Cardinal Health Business Overview Table 146. Cardinal Health Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 147. Cardinal Health Safety Lancets Product Portfolio Table 148. Cardinal Health Recent Development Table 149. BD Company Information Table 150. BD Business Overview Table 151. BD Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 152. BD Safety Lancets Product Portfolio Table 153. BD Recent Development Table 154. Ascensia Company Information Table 155. Ascensia Business Overview Table 156. Ascensia Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 157. Ascensia Safety Lancets Product Portfolio Table 158. Ascensia Recent Development Table 159. ARKRAY Company Information Table 160. ARKRAY Business Overview Table 161. ARKRAY Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 162. ARKRAY Safety Lancets Product Portfolio Table 163. ARKRAY Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Safety Lancets Distributors List Table 167. Safety Lancets Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Safety Lancets Product Image Figure 2. Global Safety Lancets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Safety Lancets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Safety Lancets Sales (2021-2032) & (M Units) Figure 5. Global Safety Lancets Sales Average Price (US$/K Unit) & (2021-2032) Figure 6. Global Safety Lancets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Safety Lancets with Needle Image Figure 10. Safety Lancets with Blade Image Figure 11. Global Safety Lancets Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 12. Global Safety Lancets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Safety Lancets Sales Volume Share by Type (2021-2032) Figure 14. Global Safety Lancets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Safety Lancets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Safety Lancets Sales Value Share by Type (2021-2032) Figure 17. Hospital & Clinics Image Figure 18. Home Image Figure 19. Other Image Figure 20. Global Safety Lancets Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 21. Global Safety Lancets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Safety Lancets Sales Volume Share by Application (2021-2032) Figure 23. Global Safety Lancets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Safety Lancets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Safety Lancets Sales Value Share by Application (2021-2032) Figure 26. Global Safety Lancets Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 27. Global Safety Lancets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Safety Lancets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Safety Lancets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Safety Lancets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Safety Lancets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Safety Lancets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Safety Lancets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Safety Lancets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Safety Lancets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Safety Lancets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Safety Lancets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Safety Lancets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Safety Lancets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Safety Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Safety Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Safety Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Safety Lancets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Safety Lancets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Safety Lancets with Needle
  • Safety Lancets with Blade
Applications
  • Hospital & Clinics
  • Home
  • Other
Companies covered
  • Tianjin Huahong
  • SteriLance Medical
  • Shandong Lianfa
  • Roche
  • Guangzhou iCare Medical
  • B. Braun
  • UltiMed
  • Terumo
  • Sarstedt
  • Owen Mumford
  • Nipro
  • Lifescan
  • ICU Medical
  • HTL-STREFA
  • HemoCue
  • Greiner Bio One
  • Cardinal Health
  • BD
  • Ascensia
  • ARKRAY

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Safety Lancets Sales Value (2021-2032)
  4. 1.2.2 Global Safety Lancets Sales Volume (2021-2032)
  5. 1.2.3 Global Safety Lancets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Safety Lancets Market Dynamics
  1. 2.1 Safety Lancets Industry Trends
  2. 2.2 Safety Lancets Industry Drivers
  3. 2.3 Safety Lancets Industry Opportunities and Challenges
  4. 2.4 Safety Lancets Industry Restraints
3 Safety Lancets Market by Company
  1. 3.1 Global Safety Lancets Company Revenue Ranking in 2025
  2. 3.2 Global Safety Lancets Revenue by Company (2021-2026)
  3. 3.3 Global Safety Lancets Sales Volume by Company (2021-2026)
  4. 3.4 Global Safety Lancets Average Price by Company (2021-2026)
  5. 3.5 Global Safety Lancets Company Ranking (2024-2026)
  6. 3.6 Global Safety Lancets Company Manufacturing Base and Headquarters
  7. 3.7 Global Safety Lancets Company Product Type and Application
  8. 3.8 Global Safety Lancets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Safety Lancets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Safety Lancets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Safety Lancets Market by Type
  1. 4.1 Safety Lancets Type Introduction
  2. 4.1.1 Safety Lancets with Needle
  3. 4.1.2 Safety Lancets with Blade
  4. 4.2 Global Safety Lancets Sales Volume by Type
  5. 4.2.1 Global Safety Lancets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Safety Lancets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Safety Lancets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Safety Lancets Sales Value by Type
  9. 4.3.1 Global Safety Lancets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Safety Lancets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Safety Lancets Sales Value Share by Type (2021-2032)
5 Safety Lancets Market by Application
  1. 5.1 Safety Lancets Application Introduction
  2. 5.1.1 Hospital & Clinics
  3. 5.1.2 Home
  4. 5.1.3 Other
  5. 5.2 Global Safety Lancets Sales Volume by Application
  6. 5.2.1 Global Safety Lancets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Safety Lancets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Safety Lancets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Safety Lancets Sales Value by Application
  10. 5.3.1 Global Safety Lancets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Safety Lancets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Safety Lancets Sales Value Share by Application (2021-2032)
6 Safety Lancets Regional Sales and Value Analysis
  1. 6.1 Global Safety Lancets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Safety Lancets Sales by Region (2021-2032)
  3. 6.2.1 Global Safety Lancets Sales by Region: 2021-2026
  4. 6.2.2 Global Safety Lancets Sales by Region (2027-2032)
  5. 6.3 Global Safety Lancets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Safety Lancets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Safety Lancets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Safety Lancets Sales Value by Region (2027-2032)
  9. 6.5 Global Safety Lancets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Safety Lancets Sales Value (2021-2032)
  12. 6.6.2 North America Safety Lancets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Safety Lancets Sales Value (2021-2032)
  15. 6.7.2 Europe Safety Lancets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Safety Lancets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Safety Lancets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Safety Lancets Sales Value (2021-2032)
  21. 6.9.2 South America Safety Lancets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Safety Lancets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Safety Lancets Sales Value Share by Country, 2025 VS 2032
7 Safety Lancets Country-level Sales and Value Analysis
  1. 7.1 Global Safety Lancets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Safety Lancets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Safety Lancets Sales by Country (2021-2032)
  4. 7.3.1 Global Safety Lancets Sales by Country (2021-2026)
  5. 7.3.2 Global Safety Lancets Sales by Country (2027-2032)
  6. 7.4 Global Safety Lancets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Safety Lancets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Safety Lancets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Safety Lancets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Safety Lancets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Safety Lancets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Safety Lancets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Safety Lancets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Safety Lancets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Safety Lancets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Safety Lancets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Safety Lancets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Safety Lancets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Safety Lancets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Safety Lancets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Safety Lancets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Safety Lancets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Safety Lancets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Safety Lancets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Safety Lancets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Safety Lancets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Safety Lancets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Safety Lancets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Safety Lancets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Safety Lancets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Safety Lancets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Safety Lancets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Safety Lancets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Safety Lancets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Safety Lancets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Safety Lancets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Safety Lancets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Safety Lancets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Safety Lancets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Safety Lancets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Safety Lancets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Safety Lancets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Safety Lancets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Safety Lancets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Safety Lancets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Safety Lancets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Safety Lancets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Safety Lancets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Safety Lancets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Safety Lancets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Safety Lancets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Safety Lancets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Safety Lancets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Safety Lancets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Safety Lancets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Safety Lancets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Safety Lancets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Safety Lancets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Safety Lancets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Safety Lancets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Safety Lancets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Safety Lancets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Safety Lancets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Safety Lancets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Safety Lancets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Safety Lancets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Safety Lancets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Safety Lancets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Safety Lancets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Safety Lancets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Safety Lancets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Safety Lancets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Safety Lancets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Safety Lancets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Safety Lancets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Safety Lancets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Safety Lancets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Safety Lancets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Safety Lancets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Safety Lancets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Safety Lancets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Safety Lancets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Safety Lancets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Safety Lancets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Safety Lancets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Safety Lancets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Safety Lancets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Safety Lancets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Safety Lancets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Safety Lancets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Safety Lancets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Safety Lancets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Tianjin Huahong
  2. 8.1.1 Tianjin Huahong Company Information
  3. 8.1.2 Tianjin Huahong Business Overview
  4. 8.1.3 Tianjin Huahong Safety Lancets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Tianjin Huahong Safety Lancets Product Portfolio
  6. 8.1.5 Tianjin Huahong Recent Developments
  7. 8.2 SteriLance Medical
  8. 8.2.1 SteriLance Medical Company Information
  9. 8.2.2 SteriLance Medical Business Overview
  10. 8.2.3 SteriLance Medical Safety Lancets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 SteriLance Medical Safety Lancets Product Portfolio
  12. 8.2.5 SteriLance Medical Recent Developments
  13. 8.3 Shandong Lianfa
  14. 8.3.1 Shandong Lianfa Company Information
  15. 8.3.2 Shandong Lianfa Business Overview
  16. 8.3.3 Shandong Lianfa Safety Lancets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Lianfa Safety Lancets Product Portfolio
  18. 8.3.5 Shandong Lianfa Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Safety Lancets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Roche Safety Lancets Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Guangzhou iCare Medical
  26. 8.5.1 Guangzhou iCare Medical Company Information
  27. 8.5.2 Guangzhou iCare Medical Business Overview
  28. 8.5.3 Guangzhou iCare Medical Safety Lancets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Guangzhou iCare Medical Safety Lancets Product Portfolio
  30. 8.5.5 Guangzhou iCare Medical Recent Developments
  31. 8.6 B. Braun
  32. 8.6.1 B. Braun Company Information
  33. 8.6.2 B. Braun Business Overview
  34. 8.6.3 B. Braun Safety Lancets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 B. Braun Safety Lancets Product Portfolio
  36. 8.6.5 B. Braun Recent Developments
  37. 8.7 UltiMed
  38. 8.7.1 UltiMed Company Information
  39. 8.7.2 UltiMed Business Overview
  40. 8.7.3 UltiMed Safety Lancets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 UltiMed Safety Lancets Product Portfolio
  42. 8.7.5 UltiMed Recent Developments
  43. 8.8 Terumo
  44. 8.8.1 Terumo Company Information
  45. 8.8.2 Terumo Business Overview
  46. 8.8.3 Terumo Safety Lancets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Terumo Safety Lancets Product Portfolio
  48. 8.8.5 Terumo Recent Developments
  49. 8.9 Sarstedt
  50. 8.9.1 Sarstedt Company Information
  51. 8.9.2 Sarstedt Business Overview
  52. 8.9.3 Sarstedt Safety Lancets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sarstedt Safety Lancets Product Portfolio
  54. 8.9.5 Sarstedt Recent Developments
  55. 8.10 Owen Mumford
  56. 8.10.1 Owen Mumford Company Information
  57. 8.10.2 Owen Mumford Business Overview
  58. 8.10.3 Owen Mumford Safety Lancets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Owen Mumford Safety Lancets Product Portfolio
  60. 8.10.5 Owen Mumford Recent Developments
  61. 8.11 Nipro
  62. 8.11.1 Nipro Company Information
  63. 8.11.2 Nipro Business Overview
  64. 8.11.3 Nipro Safety Lancets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Nipro Safety Lancets Product Portfolio
  66. 8.11.5 Nipro Recent Developments
  67. 8.12 Lifescan
  68. 8.12.1 Lifescan Company Information
  69. 8.12.2 Lifescan Business Overview
  70. 8.12.3 Lifescan Safety Lancets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Lifescan Safety Lancets Product Portfolio
  72. 8.12.5 Lifescan Recent Developments
  73. 8.13 ICU Medical
  74. 8.13.1 ICU Medical Company Information
  75. 8.13.2 ICU Medical Business Overview
  76. 8.13.3 ICU Medical Safety Lancets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 ICU Medical Safety Lancets Product Portfolio
  78. 8.13.5 ICU Medical Recent Developments
  79. 8.14 HTL-STREFA
  80. 8.14.1 HTL-STREFA Company Information
  81. 8.14.2 HTL-STREFA Business Overview
  82. 8.14.3 HTL-STREFA Safety Lancets Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 HTL-STREFA Safety Lancets Product Portfolio
  84. 8.14.5 HTL-STREFA Recent Developments
  85. 8.15 HemoCue
  86. 8.15.1 HemoCue Company Information
  87. 8.15.2 HemoCue Business Overview
  88. 8.15.3 HemoCue Safety Lancets Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 HemoCue Safety Lancets Product Portfolio
  90. 8.15.5 HemoCue Recent Developments
  91. 8.16 Greiner Bio One
  92. 8.16.1 Greiner Bio One Company Information
  93. 8.16.2 Greiner Bio One Business Overview
  94. 8.16.3 Greiner Bio One Safety Lancets Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Greiner Bio One Safety Lancets Product Portfolio
  96. 8.16.5 Greiner Bio One Recent Developments
  97. 8.17 Cardinal Health
  98. 8.17.1 Cardinal Health Company Information
  99. 8.17.2 Cardinal Health Business Overview
  100. 8.17.3 Cardinal Health Safety Lancets Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Cardinal Health Safety Lancets Product Portfolio
  102. 8.17.5 Cardinal Health Recent Developments
  103. 8.18 BD
  104. 8.18.1 BD Company Information
  105. 8.18.2 BD Business Overview
  106. 8.18.3 BD Safety Lancets Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 BD Safety Lancets Product Portfolio
  108. 8.18.5 BD Recent Developments
  109. 8.19 Ascensia
  110. 8.19.1 Ascensia Company Information
  111. 8.19.2 Ascensia Business Overview
  112. 8.19.3 Ascensia Safety Lancets Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Ascensia Safety Lancets Product Portfolio
  114. 8.19.5 Ascensia Recent Developments
  115. 8.20 ARKRAY
  116. 8.20.1 ARKRAY Company Information
  117. 8.20.2 ARKRAY Business Overview
  118. 8.20.3 ARKRAY Safety Lancets Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 ARKRAY Safety Lancets Product Portfolio
  120. 8.20.5 ARKRAY Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Safety Lancets Value Chain Analysis
  2. 9.1.1 Safety Lancets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Safety Lancets Sales Mode & Process
  6. 9.2 Safety Lancets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Safety Lancets Distributors
  9. 9.2.3 Safety Lancets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst